Cromos Pharma on clinical trial trends for 2022

2021 was a year of recalibration for the clinical trials industry as it began to recover from the impact of the COVID-19 pandemic. Although challenges remain with the emergence of new waves and variants, the adaptions the industry made during the peak of the pandemic have had a positive impact allowing the drug trials sector to rebound. What can we expect for 2022? Cromos Pharma looks at the key trends for the year ahead.

Cromos named top Quality Assurance service provider by Pharma Tech Outlook

Cromos Pharma is proud to be recognized as one of Pharma Tech Outlook's top Quality Assurance Service Providers. The latest edition which focuses on quality assurance features an interview with Cromos Pharma's CEO Vlad Bogin

Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference

The JP Morgan Healthcare Conference is recognized as one of the largest and most anticipated life science industry events. Next year's event will take place in-person January 10 -13, 2022 in San Francisco, California. Cromos Pharma's CEO Vlad Bogin is looking forward to attending and in this article gives us his take on the importance of participating in this week.

Cromos Pharma supporting clinical trials to advance HIV treatments

World AIDS Day, observed every year on December 1st, is an international day dedicated to raising awareness of HIV/AIDS, remembering those who have died, and showing support for the millions living with HIV/AIDS. 

Cromos Pharma delivering high quality data for clinical trial success

Effective data management and biostatistics are crucial for producing high quality data for successful clinical trials. At Cromos Pharma our expert data management and biostatistics team provides innovative solutions to ensure transparency, data integrity, and quality of your data. 


Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium

Cromos Pharma is delighted to be taking part again in this year's San Antonio Breast Cancer Symposium (SABCS), 7-10 December, 2021. This is the 44th year of the event which attracts a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer. 
See more